Increased vascular normalization and enhanced immunotherapy effects are observed with CCL16 in hepatocellular carcinoma, suggesting a potential therapeutic avenue.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: